Magic Empire Global expands into commodity trading, supply chain finance
Bitget2026/10/06 13:15Magic Empire Global is expanding into international commodity trading and supply chain finance, shifting to a dual-pillar model alongside Hong Kong financial services. A new wholly owned Hong Kong unit, Lunar Haste International Trading, will run cross-border trading in mineral and energy resources. The finance arm will target commodity-sector counterparties via structures such as pre-export funding, inventory financing, receivables funding. Management cited a supplier and buyer network across North America, Europe, Africa to support sourcing and distribution. The first commodity trading transaction was completed in the fourth quarter of 2026 through Lunar Haste International Trading. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Magic Empire Global Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060915PRIMZONEFULLFEED9840474) on October 06, 2026, and is solely responsible for the information contained therein.
- Magic Empire Global is expanding into international commodity trading and supply chain finance, shifting to a dual-pillar model alongside Hong Kong financial services.
- A new wholly owned Hong Kong unit, Lunar Haste International Trading, will run cross-border trading in mineral and energy resources.
- The finance arm will target commodity-sector counterparties via structures such as pre-export funding, inventory financing, receivables funding.
- Management cited a supplier and buyer network across North America, Europe, Africa to support sourcing and distribution.
- The first commodity trading transaction was completed in the fourth quarter of 2026 through Lunar Haste International Trading.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley raises CME Group price target to $337
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
Crypto prices
More
